Adapting the Scar-in-a-Jar to Skin Fibrosis and Screening Traditional and Contemporary Anti-Fibrotic Therapies.

Autor: Coentro JQ; Regenerative, Modular and Developmental Engineering Laboratory (REMODEL) and Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), National University of Ireland Galway (NUI Galway), Galway, Ireland., May U; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Prince S; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Zwaagstra J; Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC, Canada., Ritvos O; University of Helsinki, Helsinki, Finland., Järvinen TAH; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Tampere University Hospital, Tampere, Finland., Zeugolis DI; Regenerative, Modular and Developmental Engineering Laboratory (REMODEL) and Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), National University of Ireland Galway (NUI Galway), Galway, Ireland.; Regenerative, Modular and Developmental Engineering Laboratory (REMODEL), Charles Institute of Dermatology, Conway Institute of Biomolecular and Biomedical Research and School of Mechanical and Materials Engineering, University College Dublin (UCD), Dublin, Ireland.

Publikováno v: Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2021 Oct 26; Vol. 9, pp. 756399. Date of Electronic Publication: 2021 Oct 26 (Print Publication: 2021).

AlbuCORE: an albumin-based molecular scaffold for multivalent biologics design.

Autor: Sanches M; R&D, Zymeworks Inc , Vancouver, BC, Canada., D'Angelo I; One Amgen Center Dr, Amgen Inc ., Thousand Oaks, CA, USA., Jaramillo M; Human Health Therapeutics Portfolio, NRC-CNRC , Montreal, QC, Canada., Baardsnes J; Human Health Therapeutics Portfolio, NRC-CNRC , Montreal, QC, Canada., Zwaagstra J; Human Health Therapeutics Portfolio, NRC-CNRC , Montreal, QC, Canada., Schrag J; Human Health Therapeutics Portfolio, NRC-CNRC , Montreal, QC, Canada., Schoenhofen I; Human Health Therapeutics Portfolio, NRC-CNRC , Montreal, QC, Canada., Acchione M; Human Health Therapeutics Portfolio, NRC-CNRC , Montreal, QC, Canada., Lawn S; R&D, Zymeworks Inc , Vancouver, BC, Canada., Wickman G; R&D, Zymeworks Inc , Vancouver, BC, Canada., Weisser N; R&D, Zymeworks Inc , Vancouver, BC, Canada., Poon DKY; R&D, Zymeworks Inc , Vancouver, BC, Canada., Ng G; Search and Evaluation, Abbvie Inc , North Chicago, Illinois, USA., Dixit S; R&D, Zymeworks Inc , Vancouver, BC, Canada.

Publikováno v: MAbs [MAbs] 2020 Jan-Dec; Vol. 12 (1), pp. 1802188.

Increased intestinal permeability in the brain dead donor

Autor: Koudstaal, L, Nijboer, M, Zwaagstra, J, Nieuwenhuijs, V, Ploeg, R, van Goor, H, Leuvenink, H

Publikováno v: Transplant International, 20, 293-293. Wiley

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1c07ff587782564c348043f3ad82e959
http://ora.ox.ac.uk/objects/uuid:483659f3-d83c-4f5a-9d9a-c1fe69b1fe0d

Available Therapeutic Options for Corneal Neovascularization: A Review.

Autor: Drzyzga, Łukasz^1,2 (AUTHOR), Śpiewak, Dorota^1,2 (AUTHOR) dorota.spiewak7@gmail.com, Dorecka, Mariola^1,3 (AUTHOR), Wyględowska-Promieńska, Dorota^1,3 (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5479. 37p.

A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands.

Autor: Qin T; Department of Cell Systems and Anatomy, University of Texas Health Science Center, San Antonio, TX, USA.; Department of Vascular Surgery, Second Xiangya Hospital and Xiangya School of Medicine, Central South University, Hunan, China., Barron L; Department of Cell Systems and Anatomy, University of Texas Health Science Center, San Antonio, TX, USA., Xia L; Department of Cell Systems and Anatomy, University of Texas Health Science Center, San Antonio, TX, USA.; Department of Gynecology and Obstetrics, Xiangya Hospital and Xiangya School of Medicine, Central South University, Hunan, China., Huang H; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA., Villarreal MM; Department of Biochemistry, University of Texas Health Science Center, San Antonio, TX, USA., Zwaagstra J; National Research Council Human Health Therapeutics Portfolio, Montréal, Quebec, Canada, Maureen O'Connor-McCourt is currently affiliated with Formation Biologics, Montréal, Quebec, Canada., Collins C; National Research Council Human Health Therapeutics Portfolio, Montréal, Quebec, Canada, Maureen O'Connor-McCourt is currently affiliated with Formation Biologics, Montréal, Quebec, Canada., Yang J; Department of Cell Systems and Anatomy, University of Texas Health Science Center, San Antonio, TX, USA., Zwieb C; Department of Biochemistry, University of Texas Health Science Center, San Antonio, TX, USA., Kodali R; Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA., Hinck CS; Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA., Kim SK; Department of Biochemistry, University of Texas Health Science Center, San Antonio, TX, USA., Reddick RL; Department of Pathology, University of Texas Health Science Center, San Antonio, TX, USA., Shu C; Department of Vascular Surgery, Second Xiangya Hospital and Xiangya School of Medicine, Central South University, Hunan, China., O'Connor-McCourt MD; National Research Council Human Health Therapeutics Portfolio, Montréal, Quebec, Canada, Maureen O'Connor-McCourt is currently affiliated with Formation Biologics, Montréal, Quebec, Canada., Hinck AP; Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA USA., Sun LZ; Department of Cell Systems and Anatomy, University of Texas Health Science Center, San Antonio, TX, USA.; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, Texas, USA.

Publikováno v: Oncotarget [Oncotarget] 2016 Dec 27; Vol. 7 (52), pp. 86087-86102.